China Shineway Pharmaceutical Group Limited / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    (estimated) N/A N/A N/A N/A N/A
    €449.52M -16.4% €99.95M -13.4% 22.2% +0.0077 pp €131.27M +2.4% 29.2% +0.054 pp
    €537.39M +14.3% €115.35M +34.1% 21.5% +0.032 pp €128.14M -13.1% 23.8% -0.075 pp
    €470.06M +22.6% €86.00M +29.8% 18.3% +0.010 pp €147.44M +55.5% 31.4% +0.066 pp
    €383.55M +21.4% €66.23M +88.7% 17.3% +0.062 pp €94.80M +13.1% 24.7% -0.018 pp
    €315.98M -1.9% €35.10M -41.4% 11.1% -0.075 pp €83.83M +54.4% 26.5% +0.097 pp
    €321.97M +5.3% €59.87M -0.5% 18.6% -0.011 pp €54.30M -30.8% 16.9% -0.088 pp
    €305.81M +33.9% €60.19M +12.0% 19.7% -0.038 pp €78.52M +13.3% 25.7% -0.047 pp
    €228.40M -3.7% €53.73M -23.4% 23.5% -0.060 pp €69.30M -29.8% 30.3% -0.11 pp
    €237.18M -3.0% €70.10M -10.4% 29.6% -0.025 pp €98.73M -2.5% 41.6% +0.0020 pp
    €244.49M -7.8% €78.28M -6.7% 32.0% +0.0040 pp €101.29M -3.0% 41.4% +0.021 pp
    €265.24M +1.9% €83.86M +3.1% 31.6% +0.0036 pp €104.39M +12.2% 39.4% +0.036 pp
    €260.23M +2.6% €81.34M +5.5% 31.3% +0.0088 pp €93.02M -22.2% 35.7% -0.11 pp
    €253.70M +7.4% €77.07M -14.3% 30.4% -0.077 pp €119.52M +13.9% 47.1% +0.027 pp
    €236.13M -2.6% €89.90M -8.1% 38.1% -0.022 pp €104.90M -7.0% 44.4% -0.021 pp
    €242.53M +24.8% €97.77M +7.1% 40.3% -0.067 pp €112.83M -25.8% 46.5% -0.32 pp
    €194.32M +28.1% €91.30M +92.7% 47.0% +0.16 pp €152.13M +161.2% 78.3% +0.40 pp
    €151.72M +25.9% €47.38M -18.8% 31.2% -0.17 pp €58.23M -1.0% 38.4% -0.10 pp
    €120.52M +20.4% €58.38M +47.3% 48.4% +0.089 pp €58.85M +12.2% 48.8% -0.035 pp
    €100.12M +1.2% €39.62M -1.2% 39.6% -0.0097 pp €52.43M -17.0% 52.4% -0.11 pp
    €98.92M +18.2% €40.10M +29.2% 40.5% +0.035 pp €63.14M +109.5% 63.8% +0.28 pp
    €83.71M +16.5% €31.03M +72.3% 37.1% +0.12 pp €30.14M +30.0% 36.0% +0.038 pp
    €71.87M €18.01M 25.1% €23.18M 32.2%

    Notifications